logo

Assessment of the Impact of the COVID-19 Pandemic on People with Rheumatic Diseases in Europe

SCIENTIFIC
publications

The public health emergency provoked by the COVID-19 pandemic is paralleled by an economic and social crisis to which, according to research, patients with rheumatic and musculoskeletal diseases are particularly vulnerable.

Conference: European Congress of Rheumatology - EULAR 2021


Country: Europe
Date: June 2-5th 2021
Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Results from the first phase of the REUMAVID study.Country Comparison on the Impact of the COVID-19 Pandemic on Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)Gender differences on the Impact of the COVID-19 Pandemic and Lockdown in Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)Impact of the COVID-19 Pandemic and Lockdown on Wellbeing on Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)Fears and Hopes during the COVID-19 Pandemic in Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)

Conference: British Society of Rheumatology - BSR 2021

Country: UK
Date: April 26-28th 2021
Evaluation of the impact of the COVID-19 pandemic on patients with rheumatic diseases in the UK: results from the REUMAVID study

Conference: Societé Française de Rheumatologie 2020

Country: France
Evaluation of the impact of the COVID-19 pandemic on patients with rheumatic diseases in the UK: results from the REUMAVID study
CLICK HERE

Conference: American Congress of Rheumatology - ACR Convergence 2020

Conference: ACR 2020
Country: USA/br> Date: May, 19-22th 2020
Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Preliminary results from the REUMAVID study.
CLICK HERE

Conference: ongreso Nacional de la Sociedad Española de Reumatología - SER 2020

Country: Spain
Date: December 13-16th 2020
Evaluación de la pandemia COVID-19 en pacientes con enfermedades reumáticas y en España.
Resultados del estudio REUMAVID
CLICK HERE

REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)

Supported by

© 2021 All Rights Reserved

Centro de preferencias de privacidad

      Necessary

      Advertising

      Analytics

      Other

      This website uses its own and third-party cookies to analyze and improve your browsing experience. By continuing to browse, we understand that you accept their use.    More information
      Privacidad